Northwest Biotherapeutics Statistics
Total Valuation
NWBO has a market cap or net worth of 225.72 million. The enterprise value is 305.23 million.
Important Dates
The next estimated earnings date is Tuesday, March 16, 2027.
| Earnings Date | Mar 16, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
NWBO has 1.78 billion shares outstanding. The number of shares has increased by 15.65% in one year.
| Current Share Class | 1.78B |
| Shares Outstanding | 1.78B |
| Shares Change (YoY) | +15.65% |
| Shares Change (QoQ) | +4.18% |
| Owned by Insiders (%) | 3.93% |
| Owned by Institutions (%) | 0.10% |
| Float | 1.71B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 79.03 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 106.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -76.28% |
| Return on Invested Capital (ROIC) | -1,077.58% |
| Return on Capital Employed (ROCE) | 310.48% |
| Weighted Average Cost of Capital (WACC) | 3.13% |
| Revenue Per Employee | 27,200 |
| Profits Per Employee | -387,724 |
| Employee Count | 105 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -537,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.80% in the last 52 weeks. The beta is -0.62, so NWBO's price volatility has been lower than the market average.
| Beta (5Y) | -0.62 |
| 52-Week Price Change | -46.80% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 25.48 |
| Average Volume (20 Days) | 4,359,144 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NWBO had revenue of 2.86 million and -40.71 million in losses. Loss per share was -0.03.
| Revenue | 2.86M |
| Gross Profit | -17.48M |
| Operating Income | -45.95M |
| Pretax Income | -40.20M |
| Net Income | -40.71M |
| EBITDA | -42.88M |
| EBIT | -45.95M |
| Loss Per Share | -0.03 |
Full Income Statement Balance Sheet
The company has 725,000 in cash and 69.84 million in debt, with a net cash position of -69.11 million or -0.04 per share.
| Cash & Cash Equivalents | 725,000 |
| Total Debt | 69.84M |
| Net Cash | -69.11M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -46.30M |
| Book Value Per Share | -0.03 |
| Working Capital | -88.51M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -43.20 million and capital expenditures -1.29 million, giving a free cash flow of -44.49 million.
| Operating Cash Flow | -43.20M |
| Capital Expenditures | -1.29M |
| Depreciation & Amortization | 3.07M |
| Net Borrowing | 33.75M |
| Free Cash Flow | -44.49M |
| FCF Per Share | -0.02 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | -1,608.82% |
| Pretax Margin | -1,407.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NWBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -15.65% |
| Shareholder Yield | -15.65% |
| Earnings Yield | -24.63% |
| FCF Yield | -19.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on September 26, 2012. It was a reverse split with a ratio of 0.0625.
| Last Split Date | Sep 26, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.0625 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |